Word

CTX450

Status

Pending

Status Code

630

Status Date

Thursday, June 6, 2024

Serial Number

98589124

Mark Type

4

Filing Date

Thursday, June 6, 2024

Trademark Owner History

CRISPR Therapeutics AG

Classifications

5 Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of liver, neurological, and neurovascular diseases or conditions; pharmaceutical and biopharmaceutical agents for the treatment of liver, neurological, and neurovascular diseases or conditions in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of liver, neurological, and neurovascular diseases or conditions in the field of in vivo gene editing therapy

42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Trademark Events

Jun 6, 2024

New Application Entered